For the quarter ending 2025-09-30, BCYC had -$73,126K decrease in cash & cash equivalents over the period. -$71,847K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -59,100 | -139,706 |
| Share-based compensation expense | 8,771 | 19,040 |
| Depreciation and amortization | 1,756 | 3,330 |
| Deferred income tax benefit | -46 | -1,647 |
| Research and development incentives receivable | 7,614 | 20,781 |
| Prepaid expenses and other assets | 1,375 | 8,571 |
| Operating lease rightofuse assets | -1,172 | -2,235 |
| Accounts payable | -5,070 | 1,080 |
| Accrued expenses and other current liabilities | 1,121 | 972 |
| Operating lease liabilities | -1,390 | -2,656 |
| Deferred revenue | -9,398 | -12,452 |
| Net cash used in operating activities | -71,173 | -159,156 |
| Purchases of property and equipment | 674 | 1,102 |
| Net cash used in investing activities | -674 | -1,102 |
| Proceeds from the exercise of share options and settlement of restricted share units | 1 | 3 |
| Payments of finance lease obligations | 31 | 89 |
| Net cash (used in) provided by financing activities | -30 | -86 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -1,249 | 2,275 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -73,126 | -158,069 |
| Cash and cash equivalents at beginning of period | 880,067 | - |
| Cash and cash equivalents at end of period | 648,872 | - |
BICYCLE THERAPEUTICS PLC (BCYC)
BICYCLE THERAPEUTICS PLC (BCYC)